- Home
- ANNX vs NBH Comparison
ANNX vs NBH Comparison
Compare ANNX & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- NBH
- Stock Information
- Founded
- ANNX 2011
- NBH 2002
- Country
- ANNX United States
- NBH United States
- Employees
- ANNX N/A
- NBH N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- ANNX Health Care
- NBH Finance
- Exchange
- ANNX Nasdaq
- NBH Nasdaq
- Market Cap
- ANNX 263.3M
- NBH 288.5M
- IPO Year
- ANNX 2020
- NBH N/A
- Fundamental
- Price
- ANNX $2.56
- NBH $9.87
- Analyst Decision
- ANNX Strong Buy
- NBH
- Analyst Count
- ANNX 4
- NBH 0
- Target Price
- ANNX $12.50
- NBH N/A
- AVG Volume (30 Days)
- ANNX 1.8M
- NBH 85.9K
- Earning Date
- ANNX 08-11-2025
- NBH 01-01-0001
- Dividend Yield
- ANNX N/A
- NBH 4.34%
- EPS Growth
- ANNX N/A
- NBH N/A
- EPS
- ANNX N/A
- NBH 0.12
- Revenue
- ANNX N/A
- NBH N/A
- Revenue This Year
- ANNX N/A
- NBH N/A
- Revenue Next Year
- ANNX N/A
- NBH N/A
- P/E Ratio
- ANNX N/A
- NBH $87.04
- Revenue Growth
- ANNX N/A
- NBH N/A
- 52 Week Low
- ANNX $1.29
- NBH $8.75
- 52 Week High
- ANNX $7.85
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- ANNX 54.40
- NBH 47.91
- Support Level
- ANNX $1.85
- NBH $9.79
- Resistance Level
- ANNX $2.97
- NBH $9.97
- Average True Range (ATR)
- ANNX 0.27
- NBH 0.06
- MACD
- ANNX 0.00
- NBH 0.01
- Stochastic Oscillator
- ANNX 60.32
- NBH 44.44
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.